RYENX | VENAX | RYENX / VENAX | |
Total Expense Ratio | 1.65 | 0.09 | 1,833% |
Annual Report Gross Expense Ratio | 1.68 | 0.09 | 1,867% |
Fund Existence | 21 years | 21 years | - |
Gain YTD | -6.884 | -4.793 | 144% |
Front Load | 5% | N/A | - |
Min. Initial Investment | 2500 | 100000 | 3% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 14.8M | 8.09B | 0% |
Annual Yield % from dividends | 4.76 | 3.50 | 136% |
Returns for 1 year | -15.27 | -11.79 | 129% |
Returns for 3 years | 10.26 | 9.77 | 105% |
Returns for 5 years | 133.40 | 127.70 | 104% |
Returns for 10 years | -14.19 | 2.18 | -651% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MYITX | 8.50 | 0.06 | +0.71% |
NYLI WMC International Research Eq Cl A | |||
MXMGX | 35.61 | 0.11 | +0.31% |
Empower T. Rowe Price Mid Cp Gr Inv | |||
SOPAX | 29.66 | 0.04 | +0.14% |
ClearBridge Dividend Strategy A | |||
OCSGX | 6.10 | -0.03 | -0.49% |
Optimum Small-Mid Cap Growth C | |||
PGKRX | 24.84 | -0.15 | -0.60% |
PGIM Jennison Technology R6 |